2633 — Jacobson Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	315	263	221	231	340
Depreciation
Non-Cash Items	33.3	50.8	24.6	17.3	66.6
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-68.6	-119	-27.6	-34.4	39.2
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	396	361	409	407	630
Capital Expenditures	-44.1	-84.4	-63.4	-63.9	-63
Purchase of Fixed Assets
Other Investing Cash Flow Items	-583	-353	-310	13.9	-72
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-627	-438	-373	-49.9	-135
Financing Cash Flow Items	-42.7	-49.1	14.3	-26.6	-72.4
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	206	-133	21.4	-358	-36.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-26.9	-208	58.9	-1.7	458